Drug intelligence / Profile preview

soneclosan

Development stage
Unknown
Modality
Small Molecules
01

Overview

Soneclosan is a synthetic small molecule belonging to the diphenylether class, with the chemical formula C12H8Cl2O2. It is primarily recognized as an antimicrobial agent, exhibiting broad-spectrum activity against bacteria and fungi. Its mechanism of action involves inhibition of bacterial fatty acid synthesis by targeting enoyl-acyl carrier protein reductase (FabI), thereby disrupting cell membrane synthesis in susceptible microorganisms. Soneclosan has been used in personal care products, household disinfectants, and industrial applications for its preservative and biocidal properties. It is structurally related to triclosan and may be formed as a reductive dechlorination product of triclosan in environmental settings. There are no approved medical indications or marketed pharmaceutical formulations for human use; its primary uses are industrial and research-based[1][3][8].

Other names
5-chloro-2-(4-chlorophenoxy)phenolhydroxydichlorodiphenyl etherDiclosanSnoclosan
02

Targets

InhA

Beyond the preview

Go deeper on soneclosan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on soneclosan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call